Home › Compare › BCTXW vs PLD

BCTXW vs PLD: Dividend Comparison 2026

BCTXW yields 222222.22% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BCTXW wins by $1.4076449094288678e+30M in total portfolio value
10 years
BCTXW
BCTXW
● Live price
222222.22%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4076449094288678e+30M
Annual income
$1,406,399,938,745,922,600,000,000,000,000,000,000.00
Full BCTXW calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — BCTXW vs PLD

📍 BCTXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBCTXWPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BCTXW + PLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BCTXW pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BCTXW
Annual income on $10K today (after 15% tax)
$18,888,889.10/yr
After 10yr DRIP, annual income (after tax)
$1,195,439,947,934,034,100,000,000,000,000,000,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, BCTXW beats the other by $1,195,439,947,934,034,100,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BCTXW + PLD for your $10,000?

BCTXW: 50%PLD: 50%
100% PLD50/50100% BCTXW
Portfolio after 10yr
$7.038224547144339e+29M
Annual income
$703,199,969,372,961,300,000,000,000,000,000,000.00/yr
Blended yield
99.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

BCTXW
No analyst data
Altman Z
-3.9
Piotroski
2/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BCTXW buys
0
PLD buys
0
No recent congressional trades found for BCTXW or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBCTXWPLD
Forward yield222222.22% ✓3.18%
Annual dividend / share$2.00$4.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4% ✓
Portfolio after 10y$1.4076449094288678e+30M$6.50M ✓
Annual income after 10y$1,406,399,938,745,922,600,000,000,000,000,000,000.00 ✓$5,256,436.18
Total dividends collected$1.4075633997820162e+30M$6.37M ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: BCTXW vs PLD ($10,000, DRIP)

YearBCTXW PortfolioBCTXW Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$22,232,922$22,222,222.47$11,255$555.24+$22.22M → BCTXW
2$46,198,083,549$46,174,294,322.26$13,062$1,018.59+$46198.07M → BCTXW
3$89,718,755,932,306$89,669,323,982,908.17$15,903$1,926.67+$89718755.92M → BCTXW
4$162,845,400,843,462,850$162,749,401,774,615,260.00$20,839$3,823.32+$162845400843.44M → BCTXW
5$276,249,751,218,492,180,000$276,075,506,639,589,670,000.00$30,464$8,166.08+$276249751218492.16M → BCTXW
6$437,989,491,440,595,100,000,000$437,693,904,206,791,440,000,000.00$52,054$19,457.30+$437989491440595136.00M → BCTXW
7$649,026,193,150,457,500,000,000,000$648,557,544,394,616,000,000,000,000.00$109,886$54,188.93+$649026193150457544704.00M → BCTXW
8$898,874,233,030,415,400,000,000,000,000$898,179,775,003,744,500,000,000,000,000.00$304,030$186,451.18+$8.988742330304155e+23M → BCTXW
9$1,163,524,002,752,517,800,000,000,000,000,000$1,162,562,207,323,175,100,000,000,000,000,000.00$1,166,125$840,813.32+$1.1635240027525178e+27M → BCTXW
10$1,407,644,909,428,867,700,000,000,000,000,000,000$1,406,399,938,745,922,600,000,000,000,000,000,000.00$6,504,190$5,256,436.18+$1.4076449094288678e+30M → BCTXW

BCTXW vs PLD: Complete Analysis 2026

BCTXW — Stock

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Full BCTXW Calculator →

PLD — REIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this BCTXW vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BCTXW vs SCHDBCTXW vs JEPIBCTXW vs OBCTXW vs KOBCTXW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.